NCT04193475 Machine Learning in Quantitative Stress Echocardiography
| NCT ID | NCT04193475 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hull University Teaching Hospitals NHS Trust |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,250 participants |
| Start Date | 2019-11-22 |
| Primary Completion | 2021-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,250 participants in total. It began in 2019-11-22 with a primary completion date of 2021-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Greater diagnostic accuracy is required to find out who is at risk of a heart attack as this can reduce the requirement of more invasive downstream tests and thereby improve the patient experience and also reduce their exposure to risk. Stress echocardiography is a routine clinical test that involves using ultrasound to image the heart whilst it is under stress to assess the risk of a heart attack. This study will focus on developing more accurate analysis tools to interpret the results of these stress echocardiographic scans. New methods will be tested to measure the function of each part of the heart muscle, using advanced analysis of the information obtained when high-frequency sound waves are bounced off the heart inside the chest. The researchers will measure and report exact heart function during stress, so that they will be able to recognise normal hearts and those with any disease. New computer methods will be developed to display any abnormality, which will make it easier for doctors to choose the best treatment for patients who are at risk. The goals and potential benefits of this research proposal are to update the interpretation of a routinely used clinical test (stress echocardiography) to produce a reliable new method for diagnosing the precise effects of diseased arteries on the function of the heart muscle; to develop new computer graphics that adapt to show individual risks for each patient; and to implement new computer models that can be constantly updated
Eligibility Criteria
Inclusion Criteria: * Clinically suitable for stress echocardiography examination Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04193475 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 89 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04193475 currently recruiting?
Yes, NCT04193475 is actively recruiting participants. Contact the research team at imran.sunderji@nhs.net for enrollment information.
Where is the NCT04193475 trial being conducted?
This trial is being conducted at Cottingham, United Kingdom.
Who is sponsoring the NCT04193475 clinical trial?
NCT04193475 is sponsored by Hull University Teaching Hospitals NHS Trust. The trial plans to enroll 1,250 participants.